Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Conditions

• Acute Myelogenous Leukemia
• Acute Lymphocytic Leukemia
• Myelodysplastic Syndromes
• Non-Hodgkin Lymphoma
• Hodgkin Disease

Interventions

• PROCEDURE: Stem cell transplantation
• DRUG: Itacitinib
• OTHER: Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT)
• OTHER: Human Activity Profile

Sponsor

Washington University School of Medicine

Collaborators

• [object Object]
• [object Object]
• [object Object]